These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 23353080)

  • 1. Pluripotent stem cells and gene therapy.
    Simara P; Motl JA; Kaufman DS
    Transl Res; 2013 Apr; 161(4):284-92. PubMed ID: 23353080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In situ genetic correction of the sickle cell anemia mutation in human induced pluripotent stem cells using engineered zinc finger nucleases.
    Sebastiano V; Maeder ML; Angstman JF; Haddad B; Khayter C; Yeo DT; Goodwin MJ; Hawkins JS; Ramirez CL; Batista LF; Artandi SE; Wernig M; Joung JK
    Stem Cells; 2011 Nov; 29(11):1717-26. PubMed ID: 21898685
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pluripotent Stem Cells for Gene Therapy of Degenerative Muscle Diseases.
    Loperfido M; Steele-Stallard HB; Tedesco FS; VandenDriessche T
    Curr Gene Ther; 2015; 15(4):364-80. PubMed ID: 26122099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induced pluripotent stem cells in clinical hematology: potentials, progress, and remaining obstacles.
    Panopoulos AD; Belmonte JC
    Curr Opin Hematol; 2012 Jul; 19(4):256-60. PubMed ID: 22555392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Application of induced pluripotent stem cell technology for the investigation of hematological disorders.
    Dolatshad H; Tatwavedi D; Ahmed D; Tegethoff JF; Boultwood J; Pellagatti A
    Adv Biol Regul; 2019 Jan; 71():19-33. PubMed ID: 30341008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene correction in patient-specific iPSCs for therapy development and disease modeling.
    Jang YY; Ye Z
    Hum Genet; 2016 Sep; 135(9):1041-58. PubMed ID: 27256364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pluripotent Stem Cell-Based Therapeutics for Muscular Dystrophies.
    Selvaraj S; Kyba M; Perlingeiro RCR
    Trends Mol Med; 2019 Sep; 25(9):803-816. PubMed ID: 31473142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ten years of iPSC: clinical potential and advances in vitro hematopoietic differentiation.
    Paes BCMF; Moço PD; Pereira CG; Porto GS; de Sousa Russo EM; Reis LCJ; Covas DT; Picanço-Castro V
    Cell Biol Toxicol; 2017 Jun; 33(3):233-250. PubMed ID: 28039590
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modeling of hemophilia A using patient-specific induced pluripotent stem cells derived from urine cells.
    Jia B; Chen S; Zhao Z; Liu P; Cai J; Qin D; Du J; Wu C; Chen Q; Cai X; Zhang H; Yu Y; Pei D; Zhong M; Pan G
    Life Sci; 2014 Jul; 108(1):22-9. PubMed ID: 24834837
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potential of Induced Pluripotent Stem Cells for Use in Gene Therapy: History, Molecular Bases, and Medical Perspectives.
    Fus-Kujawa A; Mendrek B; Trybus A; Bajdak-Rusinek K; Stepien KL; Sieron AL
    Biomolecules; 2021 May; 11(5):. PubMed ID: 34067183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gene and Cell Therapy for β-Thalassemia and Sickle Cell Disease with Induced Pluripotent Stem Cells (iPSCs): The Next Frontier.
    Papapetrou EP
    Adv Exp Med Biol; 2017; 1013():219-240. PubMed ID: 29127683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent technological updates and clinical applications of induced pluripotent stem cells.
    Diecke S; Jung SM; Lee J; Ju JH
    Korean J Intern Med; 2014 Sep; 29(5):547-57. PubMed ID: 25228828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Embryonic and induced pluripotent stem cells: understanding, creating, and exploiting the nano-niche for regenerative medicine.
    Kingham E; Oreffo RO
    ACS Nano; 2013 Mar; 7(3):1867-81. PubMed ID: 23414366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved hematopoietic differentiation efficiency of gene-corrected beta-thalassemia induced pluripotent stem cells by CRISPR/Cas9 system.
    Song B; Fan Y; He W; Zhu D; Niu X; Wang D; Ou Z; Luo M; Sun X
    Stem Cells Dev; 2015 May; 24(9):1053-65. PubMed ID: 25517294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic Instability of iPSCs and Challenges in Their Clinical Applications.
    Yoshihara M; Oguchi A; Murakawa Y
    Adv Exp Med Biol; 2019; 1201():23-47. PubMed ID: 31898780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Application of biomaterials to advance induced pluripotent stem cell research and therapy.
    Tong Z; Solanki A; Hamilos A; Levy O; Wen K; Yin X; Karp JM
    EMBO J; 2015 Apr; 34(8):987-1008. PubMed ID: 25766254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription activator-like effector nuclease (TALEN)-mediated gene correction in integration-free β-thalassemia induced pluripotent stem cells.
    Ma N; Liao B; Zhang H; Wang L; Shan Y; Xue Y; Huang K; Chen S; Zhou X; Chen Y; Pei D; Pan G
    J Biol Chem; 2013 Nov; 288(48):34671-9. PubMed ID: 24155235
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Large Animal Models for the Clinical Application of Human Induced Pluripotent Stem Cells.
    Cong X; Zhang SM; Ellis MW; Luo J
    Stem Cells Dev; 2019 Oct; 28(19):1288-1298. PubMed ID: 31359827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem Cells.
    Tanaka A; Yuasa S; Node K; Fukuda K
    Int J Mol Sci; 2015 Aug; 16(8):18894-922. PubMed ID: 26274955
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pluripotent stem cell-based models of spinal muscular atrophy.
    Frattini E; Ruggieri M; Salani S; Faravelli I; Zanetta C; Nizzardo M; Simone C; Magri F; Corti S
    Mol Cell Neurosci; 2015 Jan; 64():44-50. PubMed ID: 25511182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.